The role of oxidative stress in organophosphate and nerve agent toxicity

Jennifer N Pearson1, Manisha Patel2,3

  • 1Neuroscience Program.

Insights

Organophosphate nerve agents cause severe neurotoxicity by inhibiting acetylcholinesterase. This review explores how oxidative stress and seizures contribute to this damage, aiding the development of new therapies.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Organophosphate (OP) nerve agents are highly toxic, inhibiting acetylcholinesterase and leading to excessive cholinergic stimulation.
  • This excessive stimulation causes rapid neuronal damage, seizures, and potentially death or long-term neurological impairment.
  • There is a critical need for medical interventions to prevent OP toxicity and delayed injury.

Purpose of the Study:

  • To review the role of reactive oxygen species (ROS) in organophosphate neurotoxicity.
  • To examine the dependence of OP-induced oxidative stress on seizure activity.
  • To understand OP-induced oxidative stress for developing targeted therapies.

Main Methods:

  • Literature review of studies on OP exposure models (subacute, acute, chronic).
  • Analysis of findings related to mitochondrial dysfunction and free radical-mediated injury.
  • Focus on the interplay between oxidative stress, seizures, and neurotoxicity.

Main Results:

  • Oxidative stress is a significant factor in OP neurotoxicity across various exposure durations.
  • Key findings include altered mitochondrial function and increased lipid peroxidation.
  • Seizure activity plays a crucial role in the development and severity of OP-induced oxidative stress.

Conclusions:

  • Reactive oxygen species are central to the neurotoxic effects of organophosphates.
  • Understanding the mechanisms of OP-induced oxidative stress, particularly its link to seizures, is vital.
  • This knowledge can guide the development of effective therapeutic strategies against OP poisoning.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.6K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
84
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
122
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
92
Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems01:15

Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
515